Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

A woman with a rare ovarian tumor and hyperparathyroidism improved after surgery, highlighting the need for reporting unusual cases to understand and manage rare diseases.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Male hypogonadism affects skin and hair, causing thin skin, less hair, and skin reactions to treatment.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

The document concludes that Polycystic Ovary Syndrome is a commonly underdiagnosed hormonal disorder in women, diagnosed by specific criteria.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

Accurate diagnosis of rare hyperandrogenism conditions requires detailed testing and sometimes invasive procedures.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

The conclusion is that hirsutism is strongly linked to PCOS and higher levels of certain hormones, but not to DHEAS, prolactin, cortisol, or TSH.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Women with prediabetes may have a higher risk of PCOS-like changes, especially if they have impaired glucose tolerance.

Men with early balding may have hormonal imbalances similar to women with PCOS and could benefit from similar treatments.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Managing emotional distress, obesity, insulin resistance, and high male hormones is crucial for improving well-being in women with PCOS.

The main cause of excessive hair growth in Turkish women is Polycystic ovary syndrome, but in about one fifth of cases, the reason for high male hormone levels is unknown.

Lower SHBG levels may increase the risk of PCOS.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Men with early hair loss and certain health factors may have a higher risk of developing reproductive issues, similar to polycystic ovary syndrome in women.

Oligomenorrhea is the strongest predictor of PCOS severity.

Skin changes in women with PCOS are mainly due to hormonal imbalances.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.